Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysis

Abstract Background Although intravenous tranexamic acid administration (ivTXA) has prevailed in clinical antifibrinolytic treatment, whether it increases thromboembolic risks has remained controversial. As a potent alternative to ivTXA, topical use of TXA (tTXA) has been successfully applied to att...

Full description

Bibliographic Details
Main Authors: Shangyi Hui, Yue Peng, Liyuan Tao, Shengru Wang, Yang Yang, You Du, Jianguo Zhang, Qianyu Zhuang, TARGETS study group
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:https://doi.org/10.1186/s13018-021-02548-6
_version_ 1798042717234659328
author Shangyi Hui
Yue Peng
Liyuan Tao
Shengru Wang
Yang Yang
You Du
Jianguo Zhang
Qianyu Zhuang
TARGETS study group
author_facet Shangyi Hui
Yue Peng
Liyuan Tao
Shengru Wang
Yang Yang
You Du
Jianguo Zhang
Qianyu Zhuang
TARGETS study group
author_sort Shangyi Hui
collection DOAJ
description Abstract Background Although intravenous tranexamic acid administration (ivTXA) has prevailed in clinical antifibrinolytic treatment, whether it increases thromboembolic risks has remained controversial. As a potent alternative to ivTXA, topical use of TXA (tTXA) has been successfully applied to attenuate blood loss in various surgical fields while minimizing systemic exposure to TXA. This meta-analysis was conducted to gather scientific evidence for tTXA efficacy on reducing postoperative drainage, blood loss, and the length of hospital stay in spine surgeries. Objectives To examine whether topical use of TXA (tTXA) reduces postoperative drainage output and duration, hidden blood loss, hemoglobin level drop, hospital stay, and adverse event rate, we reviewed both randomized and non-randomized controlled trials that assessed the aforementioned efficacies of tTXA compared with placebo in patients undergoing cervical, thoracic, or lumbar spinal surgeries. Methods An exhaustive literature search was conducted in MEDLINE and EMBASE databases from January 2000 through March 2020. Measurable outcomes were pooled using Review Manager (RevMan) version 5.0 in a meta-analysis. Results Significantly reduced postoperative drainage output (weighted mean difference [WMD]= − 160.62 ml, 95% confidence interval (95% CI) [− 203.41, − 117.83]; p < .00001) and duration (WMD= − 0.75 days, 95% CI [− 1.09, − 0.40]; p < .0001), perioperative hidden blood loss (WMD= − 91.18ml, 95% CI [− 121.42, − 60.94]; p < .00001), and length of hospital stay (WMD= − 1.32 days, 95% CI [− 1.90, − 0.74]; p < .00001) were observed in tTXA group. Pooled effect for Hb level drop with tTXA vs placebo crossed the equivalent line by a mere 0.05 g/dL, with the predominant distribution of 95% confidence interval (CI) favoring tTXA use. Conclusions With the most comprehensive literature inclusion up to the present, this meta-analysis suggests that tTXA use in spinal surgeries significantly reduces postoperative drainage, hidden blood loss, and hospital stay duration. The pooled effect also suggests that tTXA appears more effective than placebo in preserving postoperative Hb level, which needs further validation by future studies.
first_indexed 2024-04-11T22:39:21Z
format Article
id doaj.art-6005dd0ae25649bb88d0f3e7e532db39
institution Directory Open Access Journal
issn 1749-799X
language English
last_indexed 2024-04-11T22:39:21Z
publishDate 2021-06-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj.art-6005dd0ae25649bb88d0f3e7e532db392022-12-22T03:59:04ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2021-06-0116111210.1186/s13018-021-02548-6Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysisShangyi Hui0Yue Peng1Liyuan Tao2Shengru Wang3Yang Yang4You Du5Jianguo Zhang6Qianyu Zhuang7TARGETS study groupDepartment of Anesthesiology, Peking Union Medical College HospitalDepartment of Orthopedics, Peking Union Medical College HospitalResearch Center of Clinical Epidemiology, Peking University 3rd HospitalDepartment of Orthopedics, Peking Union Medical College HospitalDepartment of Orthopedics, Peking Union Medical College HospitalDepartment of Orthopedics, Peking Union Medical College HospitalDepartment of Orthopedics, Peking Union Medical College HospitalDepartment of Orthopedics, Peking Union Medical College HospitalAbstract Background Although intravenous tranexamic acid administration (ivTXA) has prevailed in clinical antifibrinolytic treatment, whether it increases thromboembolic risks has remained controversial. As a potent alternative to ivTXA, topical use of TXA (tTXA) has been successfully applied to attenuate blood loss in various surgical fields while minimizing systemic exposure to TXA. This meta-analysis was conducted to gather scientific evidence for tTXA efficacy on reducing postoperative drainage, blood loss, and the length of hospital stay in spine surgeries. Objectives To examine whether topical use of TXA (tTXA) reduces postoperative drainage output and duration, hidden blood loss, hemoglobin level drop, hospital stay, and adverse event rate, we reviewed both randomized and non-randomized controlled trials that assessed the aforementioned efficacies of tTXA compared with placebo in patients undergoing cervical, thoracic, or lumbar spinal surgeries. Methods An exhaustive literature search was conducted in MEDLINE and EMBASE databases from January 2000 through March 2020. Measurable outcomes were pooled using Review Manager (RevMan) version 5.0 in a meta-analysis. Results Significantly reduced postoperative drainage output (weighted mean difference [WMD]= − 160.62 ml, 95% confidence interval (95% CI) [− 203.41, − 117.83]; p < .00001) and duration (WMD= − 0.75 days, 95% CI [− 1.09, − 0.40]; p < .0001), perioperative hidden blood loss (WMD= − 91.18ml, 95% CI [− 121.42, − 60.94]; p < .00001), and length of hospital stay (WMD= − 1.32 days, 95% CI [− 1.90, − 0.74]; p < .00001) were observed in tTXA group. Pooled effect for Hb level drop with tTXA vs placebo crossed the equivalent line by a mere 0.05 g/dL, with the predominant distribution of 95% confidence interval (CI) favoring tTXA use. Conclusions With the most comprehensive literature inclusion up to the present, this meta-analysis suggests that tTXA use in spinal surgeries significantly reduces postoperative drainage, hidden blood loss, and hospital stay duration. The pooled effect also suggests that tTXA appears more effective than placebo in preserving postoperative Hb level, which needs further validation by future studies.https://doi.org/10.1186/s13018-021-02548-6Topical tranexamic acidSpinal surgeryPostoperative drainageBlood lossHospital stay
spellingShingle Shangyi Hui
Yue Peng
Liyuan Tao
Shengru Wang
Yang Yang
You Du
Jianguo Zhang
Qianyu Zhuang
TARGETS study group
Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysis
Journal of Orthopaedic Surgery and Research
Topical tranexamic acid
Spinal surgery
Postoperative drainage
Blood loss
Hospital stay
title Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysis
title_full Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysis
title_fullStr Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysis
title_full_unstemmed Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysis
title_short Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysis
title_sort tranexamic acid given into wound reduces postoperative drainage blood loss and hospital stay in spinal surgeries a meta analysis
topic Topical tranexamic acid
Spinal surgery
Postoperative drainage
Blood loss
Hospital stay
url https://doi.org/10.1186/s13018-021-02548-6
work_keys_str_mv AT shangyihui tranexamicacidgivenintowoundreducespostoperativedrainagebloodlossandhospitalstayinspinalsurgeriesametaanalysis
AT yuepeng tranexamicacidgivenintowoundreducespostoperativedrainagebloodlossandhospitalstayinspinalsurgeriesametaanalysis
AT liyuantao tranexamicacidgivenintowoundreducespostoperativedrainagebloodlossandhospitalstayinspinalsurgeriesametaanalysis
AT shengruwang tranexamicacidgivenintowoundreducespostoperativedrainagebloodlossandhospitalstayinspinalsurgeriesametaanalysis
AT yangyang tranexamicacidgivenintowoundreducespostoperativedrainagebloodlossandhospitalstayinspinalsurgeriesametaanalysis
AT youdu tranexamicacidgivenintowoundreducespostoperativedrainagebloodlossandhospitalstayinspinalsurgeriesametaanalysis
AT jianguozhang tranexamicacidgivenintowoundreducespostoperativedrainagebloodlossandhospitalstayinspinalsurgeriesametaanalysis
AT qianyuzhuang tranexamicacidgivenintowoundreducespostoperativedrainagebloodlossandhospitalstayinspinalsurgeriesametaanalysis
AT targetsstudygroup tranexamicacidgivenintowoundreducespostoperativedrainagebloodlossandhospitalstayinspinalsurgeriesametaanalysis